This drug is indicated in autoimmune disorders, Crohn's disease, inflammatory bowel disease.

Mild to moderate side effect has been observed such as chest pain, blood in stool, seizures, joint pain

This drug is to be cautiously used in patients with a history of hepatitis B, bleeding disorder, infection.

This drug is contraindicated in patients with heart failure.

In adults it is administered intravenously 5 mg/kg on day 1 then the second week, the sixth week then every 6 weeks.

We have also established roots and begun this new venture in other countries as well such as France, Kenya, and Oman.